GEN-MKT-18-7897-A
Aug 17, 2015 | Blogs, Food / Beverage | 0 comments
If you suffer from peanut allergies, you may want to think twice before diving into a bowl of something spicy. The reason being, some shipments of North American and European products containing ground cumin, cumin powder, cayenne pepper, paprika, and pilli-pilli powder have been found to contain undeclared peanut and almond proteins. Think dinner kits, supermarket curries, veggie and black bean burgers, and salsa.
Here is how it all started: In 2014, the Canadian Food Inspection Agency (CFIA) discovered undeclared peanut and almond protein in products containing cumin. Then, in December 2014, North American cumin samples turned up containing peanut protein. In February 2015, the FDA issued a statement declaring that people with highly sensitive peanut allergies should avoid these foods. Products containing known contaminants were then recalled in rapid succession. In all, 20 alerts were issued by the FDA and products were recalled throughout Europe. Some experts say the trace amounts of protein are the results of poor harvest and crop failure, with nuts used as a substitute. The American Spice Trade Association (ASTA) has taken a more conservative approach pointing out that spices such as cumin are grown alongside peanuts resulting in low-level cross-contact.
You can be certain labs are receiving an influx of spices for which to test. However, can we trust the results? To date, testing has not been fool-proof. Traditionally enzyme-linked immunosorbent assay (ELISA)-based methods are used for food allergen testing. However, ELISA is plagued by false positive and false negative outcomes.
What is the Solution?
Here at SCIEX, we propose a multi-allergen screening method to do the job. This LC-MS/MS application delivers:
Together, we can help keep allergens out of spices for good. To read the full application note click here.
Produced by certain moulds, thriving in crops such as grain, nuts and coffee, mycotoxins have contaminated agriculture and food production industries for a long time. To intensify the challenge, mycotoxins are resilient, not easily broken down and ensuring the safety of food supply chains requires comprehensive solutions and we are here to share those solutions with you.
Electron-Activated Dissociation (EAD) is transforming the fields of metabolomics and lipidomics by providing enhanced fragmentation techniques that offer deeper insights into molecular structures. In September, Technology Networks hosted a webinar, “Enhancing Mass-Based Omics Analysis in Model Organisms,” featuring Dr. Valentina Calabrese from the Institute of Analytical Sciences at the University of Lyon. Valentina shared her insights on improving omics-based mass spectrometry analysis for toxicology studies using model organisms, particularly in metabolomics and lipidomics. This blog explores the additional functionalities EAD offers, its benefits in untargeted workflows, its incorporation into GNPS and molecular networking, and the future role it could play in these scientific domains.
Liquid chromatography-tandem mass spectrometry (LC-MS/MS) has gained significant attention in the clinical laboratory due to its ability to provide best-in-class sensitivity and specificity for the detection of clinically relevant analytes across a wide range of assays. For clinical laboratories new to LC-MS/MS, integrating this technology into their daily routine operations may seem like a daunting task. Developing a clear outline and defining the requirements needed to implement LC-MS/MS into your daily operations is critical to maximize the productivity and success of your clinical laboratory.
Posted by
You must be logged in to post a comment.
Share this post with your network